Trident Lifeline
TLLBSE

Trident Lifeline

₹270.00-1.30 (0.48%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
266.05
Today’s high
270.60
52 week low
229.95
52 week high
328.00
Open price
270.00
Previous close
271.30
Live volume
27,000
Lower circuit
216.00
Upper circuit
324.00

Fundamentals

Market Cap
₹324Cr
ROE
18.97%
P/E Ratio(TTM)
16.76
EPS(TTM)
16.19
P/B Ratio
3.22
Dividend Yield
0.00%
Industry P/E
34.27
Book Value
84.14
Debt to Equity
0.73
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
DEC '25
Revenue (Cr)
₹30.34
-8.09%
Profit (Cr)
₹4.65
-8.64%
010203040
Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Revenue growthValue
1Y (TTM)+145%
3Y CAGR+62%
Profit growthValue
1Y (TTM)+82%
3Y CAGR+39%

About

Trident Lifeline Limited manufactures and markets pharmaceutical products, including capsules, tablets, and oral liquids, with a focus on exports to African and Asian countries.;
CEO/MD
Shravan Harikrishna Patel
Founded in
2014
BSE symbol
543616

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Promoters
62.85%
Retail And Others
29.64%
Foreign Institutions
7.24%
Other Domestic Institutions
0.27%
Livesquawk
Trident Lifeline forecasts strong FY27 due to effective strategies and projects. The positive outlook includes contributions from both parent and subsidiary levels.
2026
7
May
Annual Result
Release date
5
May
Annual Result
Release date
17
Jan
Quarterly Result
Release date
2025
11
Nov
Result
Release date
28
Jul
Quarterly Result
Release date
Events calendar
View upcoming events in other stocks